Antinucleosome autoantibody in a patient with sarcoidosis and antiphospholipid antibodies Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases Year: 2010
The lung in the antiphospholipid syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 536s Year: 2004
Pulmonary involvement in antiphospholipid syndrome Source: Eur Respir Monogr 2019; 86: 124-139 Year: 2019
Primary antiphospholipid antibody syndrome with pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 247s Year: 2004
Pulmonary manifestations of antiphospholipid syndrome: A retrospective analysis of 67 patients Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018
1 year evolution of pulmonary hypertension in patients with connective tissue diseases and secondary antiphospholipid syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 280s Year: 2004
Prevalence of pulmonary hypertension in patients with plasma lupus anticoagulant Source: Eur Respir J 2006; 28: Suppl. 50, 406s Year: 2006
Management of recurrent PE in patients on anticoagulant therapy Source: Virtual Congress 2021 – Pulmonary embolism: special situations Year: 2021
Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016
Long-term treatment with monoclonal antibodies anti-IgE in severe asthma: Follow-up of ten patients Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011
Successive treatment of Churg-Strauss syndrome with cyclesonide after oral steroids discontinuation due to side effects Source: Annual Congress 2008 - Rare clinical cases Year: 2008
The association of serum IgG antibody with symptoms of hypersensitivity pneumonitis Source: Eur Respir J 2006; 28: Suppl. 50, 675s Year: 2006
Good tolerance of aspirin in Churg-Strauss syndrome Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008
Diffuse alveolar hemorrhage caused by primary antiphospholipid syndrome Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012
Changing in the content of antiphospholipid antibodies during exacerbation of chronic simple bronchitis caused by reactivation of chronic cytomegalovirus infection (CMVI) in women in the second trimester of pregnancy Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017
New therapy for pulmonary-renal Goodpasture‘s syndrome Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008
Respiratory disease in a cohort of patients with primary antibody deficiency Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019
Development of hepatopulmonary syndrome during combination therapy for portopulmonary hypertension Source: Eur Respir J, 53 (1) 1801880; 10.1183/13993003.01880-2018 Year: 2019
Prevalence of lupus anticoagulant in patients undergoing bronchoscopy Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases Year: 2010
Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival Source: Eur Respir J 2013; 42: 1271-1282 Year: 2013